Acute emesis: moderately emetogenic chemotherapy
- 23 November 2004
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 13 (2) , 97-103
- https://doi.org/10.1007/s00520-004-0701-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004
- Randomized, Double-Blind, Dose-Finding Study of Dexamethasone in Preventing Acute Emesis Induced by Anthracyclines, Carboplatin, or Cyclophosphamide:Journal of Clinical Oncology, 2004
- Ramosetron for the Prevention of Cisplatin-Induced Acute Emesis: A Prospective Randomized Comparison with GranisetronJournal of International Medical Research, 2002
- Comparison of oral itasetron with oral ondansetronAnti-Cancer Drugs, 1997
- Oral Ondansetron 8 mg Twice Daily is as Effective as 8 mg Three Times Daily in the Prevention of Nausea and Vomiting Associated with Moderately Emetogenic Cancer ChemotherapyCancer Investigation, 1997
- Ondansetron Suppository: A Randomised, Double-Blind, Double-Dummy, Parallel-Group Comparison with Oral Ondansetron for the Prevention of Cyclophosphamide Induced Emesis and NauseaOncology, 1997
- Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapyAnti-Cancer Drugs, 1995
- Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast CancerOncology, 1992
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced EmesisJNCI Journal of the National Cancer Institute, 1991